| Structure | Chemical Name | CAS | MF |
|
ANTI-HUMAN JNK1
|
|
|
|
|
ANTI-HUMAN IGM CY3
|
|
|
|
|
2-Anthraceneisothiocyanate
|
|
C15H9NS
|
|
ANTHROSE
|
769959-88-8
|
C12H23NO6
|
|
9-Anthracenylmethyl acrylate
|
31645-34-8
|
C18H14O2
|
|
|
ANTI-HUMAN HLA-DR (CLASS II) TRI-COLOR(R) (R-PE-CY5 TANDEM)
|
|
|
|
|
ANTI-HAEMOPHILUS INFLUENZA TYPE B
|
|
|
|
|
ANTI-HUMAN ENITRIC OXIDE SYNTHASE, BIOTIN
|
|
|
|
|
ANTI-HUMAN RIT
|
|
|
|
|
ANTI-HUMAN IGM (MU-CHAIN SPECIFIC)-PEROXIDASE
|
|
|
|
|
anthra[1,2-a]benzo[h]anthracene
|
|
C30H18
|
|
|
9-anthracenecarbaldehyde [1-(1-naphthyl)-1H-tetraazol-5-yl]hydrazone
|
|
C26H18N6
|
|
|
2-[2-(9-anthrylmethylene)hydrazino]-N-(4-methylbenzyl)-2-oxoacetamide
|
|
C25H21N3O2
|
|
|
3-(9-Anthryl)-1-phenyl-5-(2-quinolyl)formazan
|
|
|
|
1,4-Anthracenedicarboxylic acid dimethyl ester
|
58791-46-1
|
|
|
9-Anthrylamine
|
779-03-3
|
|
|
Anthracene-9-carbaldehydeoxime
|
18004-57-4
|
|
|
Anthra[1,2-e]acephenanthrylene
|
28512-55-2
|
|
|
|
2,2'-(9,10-Anthrylenebismethylene)bis(isothiourea)
|
|
|
|
|
9-(9-Anthryloxy)stearic acid
|
|
|
|
|
Anthraquinonedisulfonic acid and salt(Na,K)
|
|
|
|
|
8-(Anthracen-2-yl)octanoic acid methyl ester
|
|
|
|
Anthracene-2-sulfonic acid sodium salt
|
16106-40-4
|
|
|
|
9-Anthracenecarboxylic acid (trimethylsilyl) ester
|
|
|
|
|
2,6,9-Anthracenetriol
|
|
|
|
9-Anthracenecarboxylic acid methyl
|
1504-39-8
|
|
|
2-(9-Anthrylmethylene)-3-oxobutyric acid ethyl ester
|
73758-53-9
|
|
|
|
Anthracene-1-acetic acid
|
|
|
|
Anthra[1,2-b]thiophene
|
227-86-1
|
|
|
Anthra[1,2,3,4-ghi]perylene
|
190-85-2
|
|
|
|
Anthracene-9-radical cation
|
|
|
|
|
1-[2-(Anthracen-9-yl)ethylidene]semicarbazide
|
|
|
|
1,4-Anthracenediol
|
7218-35-1
|
|
|
Anthracene-1-sulfonic acid sodium salt
|
32058-88-1
|
|
|
|
2-[(9-Anthrylmethoxy)methyl]oxirane
|
|
|
|
2-Anthracenesulfonic acid
|
15100-53-5
|
|
|
|
Anthracene-1-radical cation
|
|
|
|
2,7-Anthracenediol
|
25562-10-1
|
|
|
1-Anthracenesulfonic acid potassium salt
|
66601-70-5
|
|
|
1,5-Anthracenedicarboxylic acid dimethyl ester
|
40102-44-1
|
|
|
Anthracene 1,4-dicarboxylic acid
|
58791-45-0
|
|
|
|
3-(Anthracen-9-yloxy)stearic acid
|
|
|
|
|
5-(9-Anthracenyl)-3-methylthio-1,2,4-triazine
|
|
|
|
|
5-(9-anthrylmethylene)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one
|
|
C25H14F3NOS2
|
|
|
3-(9-anthrylmethylene)-5-(4-bromophenyl)-2(3H)-furanone
|
|
C25H15BrO2
|
|
|
ANTI-HUMAN PAN TCR GAMMA-DELTA
|
|
|
|
|
1,8-Anthraquinone Disulfonic acid Passtodium salt
|
|
|
|
9-Anthrracenecarbonitrile
|
1210-12-4
|
C15H9N
|
|
|
ANTI-HUMAN MUC3
|
|
|
|
|
ANTI-HUMAN MAST CELL TRYPTASE
|
|
|
|
|
ANTI-HUMAN B7-H2, PE
|
|
|
|
ANTHRANILOYL HYDRAZIDE
|
|
C7H9N3O
|
|
|
ANTI-HUMAN F11 RECEPTOR
|
|
|
|
|
ANTI-HUMAN AMYLOID BETA PRECURSOR PROTEIN, KPI DOMAIN
|
|
|
|
|
ANTI-HUMAN HB-EGF
|
|
|
|
|
ANTI-HUMAN CD61 R-PE
|
|
|
|
|
anthrachrysone
|
|
C14H4O2(OH)4
|
|
Anthraquinone, 1,4-bis((1,3-dimethylbutyl)amino)-
|
19720-42-4
|
|
|
|
4-(1-anthrylcarbonyl)-5-[4-(dimethylamino)phenyl]-3-hydroxy-1-phenyl-1,5-dihydro-2H-pyrrol-2-one
|
|
C33H26N2O3
|
|
|
ANTI-HES1
|
|
|
|
|
ANTI-HUMAN CD19/IGA/IGM
|
|
|
|
1,9-Pyrazoloanthrone
|
129-56-6
|
C14H8N2O
|
|
|
5-(9-anthrylmethylene)-2,4,6(1H,3H,5H)-pyrimidinetrione
|
|
C19H12N2O3
|
|
|
2-[2-(9-anthrylmethylene)hydrazino]-N-butyl-2-oxoacetamide
|
|
C21H21N3O2
|
|
|
4-(9-anthrylmethylene)-1-phenyl-3,5-pyrazolidinedione
|
|
C24H16N2O2
|
|
|
5-(9-anthrylmethylene)-1-(4-bromophenyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione
|
|
C25H15BrN2O2S
|
|
|
9-anthracenecarbaldehyde {5-nitro-2-pyridinyl}hydrazone
|
|
C20H14N4O2
|
|
|
ANTI-HUMAN CD53.1, PAN LEUCOCYTES, BLAST-1 PHYCOPROBE R-PE LABELED
|
|
|
|
|
ANTI-HORSE IGG (FC), RHODAMINE
|
|
|
|
|
ANTI-HUMAN IGF BINDING PROTEIN-4, BIOTIN
|
|
|
|
2-Anthracenecarboxamide, N-(4-(diethylamino)-1-methylbutyl)-9,10-dihyd ro-9,10-dioxo-, monohydrochloride
|
81086-04-6
|
|
|
|
Anti-human Cystatin B (RJMW 2E7)
|
|
|
|
|
anthracene perhydride
|
|
C14H24
|
|
3-Anthraniloyl-DL-alanine
|
3039-10-9
|
|
|
|
ANTI-HUMAN CD38, PE-CY5
|
|
|
|
Anthranilic acid, 4-ethoxy-3-hydroxy-, methyl ester (7CI)
|
91819-10-2
|
C10H13NO4
|
|
|
ANTI-HUMAN IP-10
|
|
|
|
2-Anthraceneacetamide, N-(4-(diethylamino)-1-methylbutyl)-9,10-dihydro -1,4-dihydroxy-9,10-dioxo-, monohydrochloride
|
81085-97-4
|
|
|
|
[2](9,10)Anthraceno[2](2,6)pyridinophane, 4,5,6,7-tetrahydro-
|
|
|
|
1-Anthraquinonesulfonic Acid Ammonium Salt
|
|
C14H11NO5S
|
|
|
Anthraquinone-2,6/2,7-Disulfonic Acid(2,6/2,7-ADA)
|
|
|
|
|
ANTI-HUMAN TGF-BETA RIII EXTRACELLULAR DOMAIN
|
|
|
|
|
ANTI-HUMAN C-RAF-1, AA 38-53
|
|
|
|
5-(anthraquinon-1-ylazo)barbituric acid
|
13325-57-0
|
C18H10N4O5
|
|
ANTHRANILIC ACID MANGANESE(II) SALT
|
15336-23-9
|
C14H12MgN2O4
|
|
|
ANTI-HLA-DR PHYCOERYTHRIN-CYANIN 5.1 CONJUGATE
|
|
|
|
|
ANTI-HUMAN MYD88 (IN)
|
|
|
|
|
ANTI-HORSE MYOGLOBIN
|
|
|
|
|
ANTI-HUMAN CD45RB TRI-COLOR(R) (R-PE-CY5 TANDEM)
|
|
|
|
|
ANTI-HUMAN C3A RECEPTOR
|
|
|
|
|
ANTI-HPV 18, E6
|
|
|
|
|
ANTI-HUMAN RHO-GDI/D4-GDI
|
|
|
|
Anthracene, 9,10-dihydro-9,10-bis(trimethylsilyl)-
|
18586-37-3
|
|
|
|
Anthracene-9,10-diide
|
|
|
|
|
3-(9-Anthryl)-1-phenyl-5-(2-pyridyl)formazan
|
|
|
|
|
Anthracene-2-carbohydroximic acid
|
|
|
|
4,4'-[Anthraquinone-1,4-diyldiiminobis(4,1-phenylene)bisoxy]bis(benzenesulfonic acid)
|
73688-63-8
|
|
|
|
(1β,5β,8-anti)-3α-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octane8-oxide
|
32663-70-0
|
|
|
|
Anthracene 1-cation
|
|
|
|
|
2-[(1-Anthracenyl)methylamino]-2-methyl-1,3-propanediol
|
|
|